ESPR ($ESPR) Insider Trading & Smart Money Activity

ESPR · Drug Manufacturers - Specialty & Generic · Latest filing Jun 17, 2026

$ESPR has 6 insider trades on file. In the last 12 months on the open market, no insider bought and 3 insiders sold ($481.49K), net -$481.49K.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
3
Net insider $ (12 mo)
-$481.49K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

ESPR insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 6 · $481.49K 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ESPR insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Benjamin LookerChief Legal Officer Sell (Open-market sale) 11.82K sh $37.36K —
Insider Benjamin LookerChief Legal Officer Sell (Open-market sale) 11.82K sh $37.36K Read
Insider Sheldon KoenigPresident and CEO Sell (Open-market sale) 53.59K sh $169.34K —
Insider Sheldon KoenigPresident and CEO Sell (Open-market sale) 53.59K sh $169.34K Read
Insider Benjamin HalladayChief Financial Officer Sell (Open-market sale) 10.77K sh $34.04K —
Insider Benjamin HalladayChief Financial Officer Sell (Open-market sale) 10.77K sh $34.04K Read

1W / 1M / 6M = how ESPR moved from the trade or filing date.

Insider trading in ESPR: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Benjamin Looker Chief Legal Officer 2 -$74.73K Jun 17, 2026
Sheldon Koenig President and CEO 2 -$338.68K Jun 17, 2026
Benjamin Halladay Chief Financial Officer 2 -$68.09K Jun 17, 2026

Frequently asked questions

Are ESPR insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 3 insiders made 6 open-market sales worth $481.49K, a net -$481.49K.

What is the latest insider trade in ESPR?

Benjamin Looker, Chief Legal Officer filed a sell (open-market sale) of 11.82K sh worth $37.36K on Jun 17, 2026.

Other drug manufacturers - specialty & generic stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text